{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:17:27Z","timestamp":1790309847372,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cardfail.2025.01.028","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T19:47:02Z","timestamp":1741031222000},"page":"1051-1061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Therapeutic Ketosis for Heart Failure: A State-of-the-Art Review"],"prefix":"10.1016","volume":"31","author":[{"given":"NANDAN","family":"KODUR","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHRISTOPHER","family":"NGUYEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-735X","authenticated-orcid":false,"given":"W. H. WILSON","family":"TANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.cardfail.2025.01.028_bib0001","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.cardfail.2025.01.028_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5152\/akd.2014.5731","article-title":"Mortality in heart failure patients","volume":"15","author":"Byty\u00e7i","year":"2015","journal-title":"Anatolian Journal of Cardiology"},{"issue":"11","key":"10.1016\/j.cardfail.2025.01.028_bib0003","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ejhf.1594","article-title":"Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis","volume":"21","author":"Jones","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10.1016\/j.cardfail.2025.01.028_bib0004","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.jacc.2020.12.065","article-title":"Therapeutic Potential of Ketone Bodies for Patients With Cardiovascular Disease","volume":"77","author":"Yurista","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0005","article-title":"Beyond Guideline-Directed Medical Therapy: Nonpharmacologic Management for Patients With Heart Failure","author":"Ilonze","year":"2024","journal-title":"JACC: Heart Fail"},{"issue":"9","key":"10.1016\/j.cardfail.2025.01.028_bib0006","first-page":"1509","article-title":"Obesity and Weight Loss Strategies for Patients With Heart Failure","volume":"12","author":"Vest","year":"2024","journal-title":"JACC: Heart Fail"},{"issue":"10","key":"10.1016\/j.cardfail.2025.01.028_bib0007","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","article-title":"Cardiac Energy Metabolism in Heart Failure","volume":"128","author":"Lopaschuk","year":"2021","journal-title":"Circulat Res"},{"issue":"22","key":"10.1016\/j.cardfail.2025.01.028_bib0008","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1161\/CIRCULATIONAHA.119.045033","article-title":"Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure","volume":"141","author":"Selvaraj","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.cardfail.2025.01.028_bib0009","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJMra063052","article-title":"The Failing Heart\u2014An Engine Out of Fuel","volume":"356","author":"Neubauer","year":"2007","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.cardfail.2025.01.028_bib0010","article-title":"Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling","volume":"11","author":"Voros","year":"2018","journal-title":"Circulation: Heart Failure"},{"issue":"3","key":"10.1016\/j.cardfail.2025.01.028_bib0011","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0735-1097(96)00214-8","article-title":"Blood ketone bodies in congestive heart failure","volume":"28","author":"Lommi","year":"1996","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.cardfail.2025.01.028_bib0012","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for Intramyocardial Disruption of Lipid Metabolism and Increased Myocardial Ketone Utilization in Advanced Human Heart Failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"issue":"6514","key":"10.1016\/j.cardfail.2025.01.028_bib0013","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.abc8861","article-title":"Comprehensive quantification of fuel use by the failing and nonfailing human heart","volume":"370","author":"Murashige","year":"2020","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.cardfail.2025.01.028_bib0014","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial Metabolomics of Human Heart Failure With Preserved Ejection Fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cardfail.2025.01.028_bib0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124079","article-title":"The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense","volume":"4","author":"Horton","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0016","first-page":"154","article-title":"Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation","author":"Pherwani","year":"2024","journal-title":"Metabolism - Clinical and Experimental"},{"issue":"18","key":"10.1016\/j.cardfail.2025.01.028_bib0017","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1161\/CIRCULATIONAHA.118.036459","article-title":"Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients","volume":"139","author":"Nielsen","year":"2019","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cardfail.2025.01.028_bib0018","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033628","article-title":"Enantiomer-Specific Cardiovascular Effects of the Ketone Body 3-Hydroxybutyrate","volume":"13","author":"Gopalasingam","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.cardfail.2025.01.028_bib0019","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<412::AID-DMRR72>3.0.CO;2-8","article-title":"Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes","volume":"15","author":"Laffel","year":"1999","journal-title":"Diabetes\/Metab Rev"},{"issue":"1","key":"10.1016\/j.cardfail.2025.01.028_bib0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12916-021-02185-0","article-title":"Ketone bodies: from enemy to friend and guardian angel","volume":"19","author":"Kolb","year":"2021","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.cardfail.2025.01.028_bib0021","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/osp4.516","article-title":"Measuring ketone bodies for the monitoring of pathologic and therapeutic ketosis","volume":"7","author":"Anderson","year":"2021","journal-title":"Obes Sci Pract"},{"issue":"10","key":"10.1016\/j.cardfail.2025.01.028_bib0022","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3949\/ccjm.88a.20121","article-title":"Ketogenic diets in the management of type 1 diabetes: Safe or safety concern?","volume":"88","author":"Buehler","year":"2021","journal-title":"CCJM"},{"issue":"7","key":"10.1016\/j.cardfail.2025.01.028_bib0023","first-page":"838","article-title":"Ketogenic Diet in Heart Failure: Fact or Fiction?\u2217","volume":"11","author":"Kodur","year":"2023","journal-title":"JACC: Heart Fail"},{"issue":"1","key":"10.1016\/j.cardfail.2025.01.028_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00125-022-05815-1","article-title":"Ketones: the double-edged sword of SGLT2 inhibitors?","volume":"66","author":"Lupsa","year":"2023","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.cardfail.2025.01.028_bib0025","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.clnu.2023.04.027","article-title":"A ketogenic diet substantially reshapes the human metabolome","volume":"42","author":"Effinger","year":"2023","journal-title":"Clin Nutrit"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0026","doi-asserted-by":"crossref","unstructured":"Selvaraj S, Kwee LC, Thompson EJ, He M, Hornik CP, Devore AD, et al. Metabolic and pharmacokinetic profiling of an exogenous ketone ester by background SGLT2 inhibitor therapy in heart failure with reduced ejection. JACC: Basic Translat Sci Accessed Nov 18, 2024. Available at: https:\/\/www.jacc.org\/doi\/10.1016\/j.jacbts.2024.10.014","DOI":"10.1161\/circ.150.suppl_1.4116177"},{"issue":"3","key":"10.1016\/j.cardfail.2025.01.028_bib0027","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1152\/physiol.00031.2023","article-title":"Emerging Pathophysiological Roles of Ketone Bodies","volume":"39","author":"Tsuruta","year":"2024","journal-title":"Physiology"},{"issue":"7","key":"10.1016\/j.cardfail.2025.01.028_bib0028","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0735-1097(03)00946-X","article-title":"Is nutritional intake adequate in chronic heart failure patients?","volume":"42","author":"Aquilani","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.cardfail.2025.01.028_bib0029","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ehf2.13255","article-title":"Sarcopenia in heart failure: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3389\/fcvm.2019.00015","article-title":"Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction","volume":"6","author":"Zeng","year":"2019","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.cardfail.2025.01.028_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00395-023-01008-y","article-title":"Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility","volume":"118","author":"Homilius","year":"2023","journal-title":"Basic Res Cardiol"},{"issue":"10","key":"10.1016\/j.cardfail.2025.01.028_bib0032","first-page":"1337","article-title":"Beneficial Effects of Ketone Ester in Patients With Cardiogenic Shock","volume":"11","author":"Berg-Hansen","year":"2023","journal-title":"JACC: Heart Fail"},{"issue":"19","key":"10.1016\/j.cardfail.2025.01.028_bib0033","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/CIRCULATIONAHA.123.067971","article-title":"Cardiovascular Effects of Oral Ketone Ester Treatment in Patients With Heart Failure With Reduced Ejection Fraction: A Randomized, Controlled, Double-Blind Trial","volume":"149","author":"Berg-Hansen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0034","unstructured":"Berg-Hansen K, Gopalasingam N, Christensen KH, Svart M, Rittig N, Nielsen R. et al. Neurohormonal and renal effects of 14-day oral ketone ester treatment in patients with heart failure with reduced ejection fraction. Circulation: Heart Fail; e012167."},{"issue":"15","key":"10.1016\/j.cardfail.2025.01.028_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013039","article-title":"Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization","volume":"9","author":"Brahma","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0036","doi-asserted-by":"crossref","unstructured":"Gopalasingam N, Berg-Hansen K, Christensen KH, Ladefoged BT, Poulsen SH, Andersen MJ. et al. Randomized crossover trial of 2-week ketone ester treatment in patients with type 2 diabetes and heart failure with preserved ejection fraction. Circulation AccessedSep 28, 2024 Available at: https:\/\/www.ahajournals.org\/doi\/abs\/10.1161\/CIRCULATIONAHA.124.069732","DOI":"10.1161\/CIRCULATIONAHA.124.069732"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0037","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038461","article-title":"Cardiovascular and metabolic effects of modulating circulating ketone bodies with 1,3-butanediol in patients with heart failure with reduced ejection fraction","volume":"14","author":"Guldbrandsen","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"20","key":"10.1016\/j.cardfail.2025.01.028_bib0038","doi-asserted-by":"crossref","first-page":"eado1463","DOI":"10.1126\/sciadv.ado1463","article-title":"Ketogenic diet induces p53-dependent cellular senescence in multiple organs","volume":"10","author":"Wei","year":"2024","journal-title":"Sci Advan"},{"issue":"10","key":"10.1016\/j.cardfail.2025.01.028_bib0039","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/cvr\/cvae092","article-title":"The ketogenic diet does not improve cardiac function and blunts glucose oxidation in ischaemic heart failure","volume":"120","author":"Ho","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0040","doi-asserted-by":"crossref","unstructured":"Iatan I, Huang K, Vikulova D, Ranjan S, Brunham LR. Association of a low-carbohydrate high-fat diet with plasma lipid levels and cardiovascular risk. JACC: Advan. Accessed June 11, 2024. Available at:https:\/\/www.jacc.org\/doi\/10.1016\/j.jacadv.2024.100924","DOI":"10.1016\/j.jacadv.2024.100924"},{"issue":"12","key":"10.1016\/j.cardfail.2025.01.028_bib0041","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.cardfail.2015.10.002","article-title":"Effect of a Sodium-Restricted Diet on Intake of Other Nutrients in Heart Failure: Implications for Research and Clinical Practice","volume":"21","author":"Jefferson","year":"2015","journal-title":"J Card Fail"},{"issue":"5","key":"10.1016\/j.cardfail.2025.01.028_bib0042","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejcnurse.2009.05.005","article-title":"Heart failure patients' perceptions on nutrition and dietary adherence","volume":"8","author":"Heo","year":"2009","journal-title":"Eur J Cardiovasc"},{"issue":"9","key":"10.1016\/j.cardfail.2025.01.028_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239656","article-title":"Comparison of learning needs priorities between healthcare providers and patients with heart failure","volume":"15","author":"Min","year":"2020","journal-title":"PLoS ONE"},{"issue":"21","key":"10.1016\/j.cardfail.2025.01.028_bib0044","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMra2115011","article-title":"Gliflozins in the Management of Cardiovascular Disease","volume":"386","author":"Braunwald","year":"2022","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.cardfail.2025.01.028_bib0045","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1136\/heartjnl-2020-318060","article-title":"Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure","volume":"107","author":"Joshi","year":"2021","journal-title":"Heart"},{"issue":"16","key":"10.1016\/j.cardfail.2025.01.028_bib0046","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/cvr\/cvad157","article-title":"Empagliflozin improves cardiac energetics during ischaemia\/reperfusion by directly increasing cardiac ketone utilization","volume":"119","author":"Chase","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.cardfail.2025.01.028_bib0047","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1161\/CIRCULATIONAHA.122.060402","article-title":"Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF","volume":"146","author":"Selvaraj","year":"2022","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cardfail.2025.01.028_bib0048","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1542\/pir.2018-0231","article-title":"Diabetic Ketoacidosis","volume":"40","author":"Cashen","year":"2019","journal-title":"Pediatr Rev"},{"issue":"1","key":"10.1016\/j.cardfail.2025.01.028_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.nutr.26.061505.111258","article-title":"Fuel Metabolism in Starvation","volume":"26","author":"Cahill","year":"2006","journal-title":"Ann Rev Nutrit"},{"issue":"1","key":"10.1016\/j.cardfail.2025.01.028_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00831-w","article-title":"Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations","volume":"7","author":"Zhu","year":"2022","journal-title":"Sig Transduct Target Ther"},{"issue":"10","key":"10.1016\/j.cardfail.2025.01.028_bib0051","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.2337\/dci23-0036","article-title":"Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus","volume":"46","author":"Sacks","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cardfail.2025.01.028_bib0052","series-title":"Endotext","article-title":"Hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state","author":"Gosmanov","year":"2000"},{"issue":"5","key":"10.1016\/j.cardfail.2025.01.028_bib0053","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/osp4.432","article-title":"Urine dipsticks are not accurate for detecting mild ketosis during a severely energy restricted diet","volume":"6","author":"Gibson","year":"2020","journal-title":"Obes Sci Pract"},{"issue":"7","key":"10.1016\/j.cardfail.2025.01.028_bib0054","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/dme.12136","article-title":"Blood \u03b2-hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review","volume":"30","author":"Klocker","year":"2013","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.cardfail.2025.01.028_bib0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1056\/NEJMc052709","article-title":"Ketoacidosis during a Low-Carbohydrate Diet","volume":"354","author":"Shah","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916425001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T13:18:57Z","timestamp":1777641537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916425001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1071916425001010"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.01.028","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Ketosis for Heart Failure: A State-of-the-Art Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2025.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}